IBMS 2023

Jacqueline Reyner, Sr Account Manager, Clinical Sequencing Division, Thermo Fisher Scientific

Pharmacogenomics solutions for clinical and translational research

Tuesday, 9/26
11:15 - 12:30

Overview

In this session we will present our latest solutions for Pharmacogenomics for customers interested in clinical & translational research applications. Thermo Fisher Scientific does offer technologies for different needs related to marker coverage, number of markers and turn around time. Our technologies range from qPCR, Microarrays to Next-Generation Sequencing.

Learning Objectives

1. Overview of Thermo Fisher Scientifics solutions for Pharmacogenomics
2. Latest use cases and publications

Ross Stevenson, Sr Sales Manager, Thermo Fisher Scientific

Connecting Patients everywhere to precision oncology  | Oncomine Dx Express Test

Tuesday, 9/26
12:45 - 13:45 (Lunch)

Overview

Genomic profiling in precision oncology is transforming cancer care for your patients. But long waiting periods for biomarker test results from the lab can delay therapy decisions, with potential consequences for the patient’s outcomes. Learn about a new NGS test for precision oncology biomarker testing based on an end-to-end NGS workflow solution which can deliver results in as little as 24 hours.

Learning Objectives

1. Generate clinically relevant biomarker results in as little as24 hours
2. Integrate molecular biomarker profiling, including EGFR, BRAF, KRAS, ERBB2, ALK, ROS1, RET, MET, and NTRK1/2/3, among others, with PD-L1 results, into one complete report
3. Match biomarker results to approved therapies, guidelines, and clinical trials
4. Provide results for even small samples, thereby limiting the need for re-biopsy

Jacqueline Reyner, Sr Account Manager, Clinical Sequencing Division, Thermo Fisher Scientific

NEW: TaqPath Menu I GeneProof PCR Kits for Molecular Diagnostics

Wednesday, 9/27
9:15 - 10:30

Overview

In this session we will introduce our Molecular Diagnostic qPCR CE-IVD tests for the detection of infectious disease and thrombotic mutations. Our TaqPath Menu I GeneProof qPCR CE-IVD kits for infectious disease cover sexually transmitted infections, respiratory infections, as well as targets for monitoring infections in transplanted tissues and in immunocompromised patients.

Learning Objectives

1. Understand Thermo Fisher Scientific's broad portfolio of Molecular Diagnostic qPCR CE-IVD kits
2. Learn more about the ease-of use and simple laboratory workflow of these qPCR kits

Robert Eardley, Sr Product Manager, Thermo Fisher Scientific

Rapid lung NGS connects patients to precision oncology

Wednesday, 9/27
12:00 - 13:15 (Lunch)

Overview

Targeted cancer genomic profiling is guiding cancer therapy and  improving patients outcomes. In this session we will show how:

• patients treated in first line based on their genomic profile have 22% higher probability of survival two years from diagnosis.
•  gaps in a process of providing oncologists with the genomic profile data in time are hindering patients access to the treatments they could potentially benefit from.
  

In house rapid and tissue saving NGS can address all the main gaps.

Learning Objectives

1. Understand why timely results delivery is important in clinical setting
2. Know the gaps in testing access and adequacy and learn how rapid NGS can address them
3. Learn that not all NGS are the same: Amplicon-based NGS can increase access to targeted therapy for NSCLC patients otherwise not eligible with hyb-capture NGS due to QNS related failures

Kartikki Thakur, Clinical Account Manager,
Clinical Sequencing Division, Thermo Fisher Scientific

Unlocking more blood cancer insights with NGS

Thursday, 9/28
12:00 - 13:15 (Lunch)

Overview

Hematological disorders are complex, heterogeneous diseases with many oncogenic drivers and subtypes. Acute malignancies are very aggressive and can proliferate rapidly. Getting fast, accurate, and meaningful insights is essential in helping to advance our understanding of these diseases. Whether you’re interested in genomic profiling for myeloid or lymphoid malignancies or immune repertoire analysis, we provide a comprehensive suite comprehensive suite of next-generation sequencing (NGS) solutions to help simplify and expedite your path to answers.

Learning Objectives

1. Overview of Thermo Fisher Scientifics Oncomine Hemato-Oncology research solutions.
2. Understand how workflow automation can accelerate turnaround time for NGS results and decrease hands-on time for lab technicians.
3. Learn how NGS can support rapid integrated analysis across several genetic biomarkers, while reducing the need for many individual single-gene tests in haemato-oncology research.

Kartikki Thakur, Clinical Account Manager,
Clinical Sequencing Division, Thermo Fisher Scientific